COMPANIES COVERED
GlaxoSmithKlineDownload FREE Report Sample
Download Free sampleBipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in mood, energy, activity levels, and the ability to carry out day-to-day tasks.
Bipolar Disorders and Treatment Market contains market size and forecasts of Bipolar Disorders and Treatment in Global, including the following market information:
Global Bipolar Disorders and Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Bipolar Disorders and Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Mood Stabilizer Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Bipolar Disorders and Treatment include GlaxoSmithKline, Pfizer, Janssen Pharmaceuticals, Eli Lilly, Allergan, Novartis, ??AbbVie, Otsuka Holdings and AstraZeneca. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Bipolar Disorders and Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bipolar Disorders and Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Bipolar Disorders and Treatment Market Segment Percentages, by Type, 2021 (%)
Mood Stabilizer
Anticonvulsant
Antipsychotic
Antidepressant
Antianxiety
Global Bipolar Disorders and Treatment Market, by Sale Channel, 2017-2022, 2023-2028 ($ millions)
Global Bipolar Disorders and Treatment Market Segment Percentages, by Sale Channel, 2021 (%)
Hospital
Pharmacy
Other
Global Bipolar Disorders and Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Bipolar Disorders and Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bipolar Disorders and Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Bipolar Disorders and Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Pfizer
Janssen Pharmaceuticals
Eli Lilly
Allergan
Novartis
??AbbVie
Otsuka Holdings
AstraZeneca
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
